EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 3.0

Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease

Eun Kyung Kim iD, Eunyoung Lee, Ji Eun Park, Jae Seung Lee iD, Hye Sook Choi iD, Bumhee Park, Seung Soo Sheen iD, Kwang Joo Park, Chin Kook Rhee iD, Sang Yeub Lee, Kwang Ha Yoo iD, Joo Hun Park

International Journal of Chronic Obstructive Pulmonary Disease · 2024-01 · Volume 19 · 243-254

DOI: 10.2147/copd.s433583 ↗

At a glance

Journal article in International Journal of Chronic Obstructive Pulmonary Disease, 2024-01. Written by Eun Kyung Kim and 11 co-authors. Institution: Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Atrial Fibrillation, Myocardial Ischemia, Heart Failure. Cited 7 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

COPD coexists with many concurrent comorbidities. Cardiovascular complications are deemed to be major causes of death in COPD. Although inhaler therapy is the main therapeutic intervention in COPD, cardiovascular events accompanying inhaler therapy require further investigation. Therefore, this study aimed to investigate new development of cardiovascular events according to each inhaler therapy and comorbidities.

Methods

This study analyzed COPD patients (age ≥ 40 years, N = 199,772) from the Health Insurance Review and Assessment Service (HIRA) database in Korea. The development of cardiovascular events, from the index date to December 31, 2020, was investigated. The cohort was eventually divided into three arms: the LAMA/LABA group (N = 28,322), the ICS/LABA group (N = 11,812), and the triple group (LAMA/ICS/LABA therapy, N = 6174).

Results

Multivariable Cox analyses demonstrated that, compared to ICS/LABA therapy, triple therapy was independently associated with the development of ischemic heart disease (HR: 1.22, 95% CI: 1.04-1.43), heart failure (HR: 1.45, 95% CI: 1.14-1.84), arrhythmia (HR: 1.72, 95% CI: 1.41-2.09), and atrial fibrillation/flutter (HR: 2.31, 95% CI: 1.64-3.25), whereas the LAMA/LABA therapy did not show a significant association. Furthermore, emergency room visit during covariate assessment window was independently associated with the development of ischemic heart disease, heart failure, arrhythmia, and atrial fibrillation/flutter (p < 0.05).

Conclusion

Our data suggest that cardiovascular risk should be considered in COPD patients receiving triple therapy, despite the confounding bias resulting from disparities in each group.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAtrial FibrillationMyocardial IschemiaHeart FailureHumansAdultNebulizers and Vaporizers

Author keywords

COPDcardiovascular eventcomorbiditiesinhaler therapy

Authors and institutions

  • Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Department of Neurology, McGovern Medical School at UTHealth, Houston, TX, USA.
  • Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Republic of Korea.
  • Office of Biostatistics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Republic of Korea.

ORCID profiles: Eun Kyung Kim, Jae Seung Lee, Hye Sook Choi, Seung Soo Sheen, Chin Kook Rhee, Kwang Ha Yoo

Cite

APA

Kim, E. K., Lee, E., Park, J. E., Lee, J. S., Choi, H. S., Park, B., Sheen, S. S., Park, K. J., Rhee, C. K., Lee, S. Y., Yoo, K. H., & Park, J. H. (2024). Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 243-254. https://doi.org/10.2147/copd.s433583

Vancouver

Kim EK, Lee E, Park JE, Lee JS, Choi HS, Park B, et al. Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:243-254. doi:10.2147/copd.s433583

BibTeX
@article{Kim2024,
  author = {Kim, Eun Kyung and Lee, Eunyoung and Park, Ji Eun and Lee, Jae Seung and Choi, Hye Sook and Park, Bumhee and Sheen, Seung Soo and Park, Kwang Joo and Rhee, Chin Kook and Lee, Sang Yeub and Yoo, Kwang Ha and Park, Joo Hun},
  title = {Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  volume = {Volume 19},
  pages = {243--254},
  doi = {10.2147/copd.s433583}
}
Start for free →